Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to our Researcher latest study, the global Intravitreal (IVT) Injectables market size was valued at USD 14950 million in 2023 and is forecast to a readjusted size of USD 22520 million by 2030 with a CAGR of 6.0% during review period.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
The Global Info Research report includes an overview of the development of the Intravitreal (IVT) Injectables industry chain, the market status of Hospital Pharmacies (Anti-VEGF, Corticosteroids), Retail Pharmacies (Anti-VEGF, Corticosteroids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravitreal (IVT) Injectables.
Regionally, the report analyzes the Intravitreal (IVT) Injectables markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravitreal (IVT) Injectables market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravitreal (IVT) Injectables market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravitreal (IVT) Injectables industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Anti-VEGF, Corticosteroids).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravitreal (IVT) Injectables market.
Regional Analysis: The report involves examining the Intravitreal (IVT) Injectables market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravitreal (IVT) Injectables market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravitreal (IVT) Injectables:
Company Analysis: Report covers individual Intravitreal (IVT) Injectables manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravitreal (IVT) Injectables This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Intravitreal (IVT) Injectables. It assesses the current state, advancements, and potential future developments in Intravitreal (IVT) Injectables areas.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Intravitreal (IVT) Injectables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravitreal (IVT) Injectables, with price, sales, revenue and global market share of Intravitreal (IVT) Injectables from 2019 to 2024.
Chapter 3, the Intravitreal (IVT) Injectables competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal (IVT) Injectables breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravitreal (IVT) Injectables market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal (IVT) Injectables.
Chapter 14 and 15, to describe Intravitreal (IVT) Injectables sales channel, distributors, customers, research findings and conclusion.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
The Global Info Research report includes an overview of the development of the Intravitreal (IVT) Injectables industry chain, the market status of Hospital Pharmacies (Anti-VEGF, Corticosteroids), Retail Pharmacies (Anti-VEGF, Corticosteroids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravitreal (IVT) Injectables.
Regionally, the report analyzes the Intravitreal (IVT) Injectables markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravitreal (IVT) Injectables market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravitreal (IVT) Injectables market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravitreal (IVT) Injectables industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Anti-VEGF, Corticosteroids).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravitreal (IVT) Injectables market.
Regional Analysis: The report involves examining the Intravitreal (IVT) Injectables market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravitreal (IVT) Injectables market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravitreal (IVT) Injectables:
Company Analysis: Report covers individual Intravitreal (IVT) Injectables manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravitreal (IVT) Injectables This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Intravitreal (IVT) Injectables. It assesses the current state, advancements, and potential future developments in Intravitreal (IVT) Injectables areas.
Competitive Landscape
: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravitreal (IVT) Injectables market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others
Major players
coveredRegeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravitreal (IVT) Injectables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravitreal (IVT) Injectables, with price, sales, revenue and global market share of Intravitreal (IVT) Injectables from 2019 to 2024.
Chapter 3, the Intravitreal (IVT) Injectables competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal (IVT) Injectables breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravitreal (IVT) Injectables market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal (IVT) Injectables.
Chapter 14 and 15, to describe Intravitreal (IVT) Injectables sales channel, distributors, customers, research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
